Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.19 -0.25 (-1.22%)
At close: Oct 21, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Gross Margin (2016 - 2026)

Updated

Acadia Pharmaceuticals' Gross Margin was 90.81% in Q2 2026, down 1.36 percentage points from 92.16% a year earlier but up 0.05 percentage points from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Gross Margin (2016 - 2026) Analysis & Trends

On a trailing twelve-month basis, Acadia Pharmaceuticals' Gross Margin was 91.13% through Jun 30, 2026, down 0.84 percentage points year-over-year; for FY2025, it came in at 91.69%, up 0.24 percentage points from FY2024.

  • Gross Margin shows a five-year change of -5.99 percentage points (FY2020 to FY2025).
  • In earlier years, Gross Margin was 91.46% in FY2024 (-2.81 pp), 94.27% in FY2023 (-3.77 pp), 98.03% in FY2022 (+1.99 pp) and 96.05% in FY2021 (-1.64 pp).
  • Quarterly Gross Margin has moved between 88.85% (Q1 2024) and 98.59% (Q1 2023) over five years.
  • Compared with a year earlier, Gross Margin has declined for five straight quarters, with an average year-over-year change of -0.26 percentage points over the last eight quarters.
  • The best year-over-year quarter for Gross Margin over five years was Q4 2022 (a gain of 6.45 percentage points); the worst was Q1 2024 (a drop of 9.74 percentage points).
  • Per Business Quant data, ACAD's Gross Margin in the three quarters before Q2 2026 was 90.75% (Q1 2026), 90.77% (Q4 2025) and 92.23% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 85.78%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 68.19%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 74.74%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 73.54%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 78.02%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 83.60%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 72.04%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 79.76%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 72.78%
10 Acadia Pharmaceuticals 3.47 Bn -4.91 Mn 279.64 Mn 90.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90.81%
Mar 31, 2026 90.75%
Dec 31, 2025 90.77%
Sep 30, 2025 92.23%
Jun 30, 2025 92.16%
Mar 31, 2025 91.65%
Dec 31, 2024 91.60%
Sep 30, 2024 92.47%
Jun 30, 2024 92.47%
Mar 31, 2024 88.85%
Dec 31, 2023 92.26%
Sep 30, 2023 93.09%
Jun 30, 2023 95.49%
Mar 31, 2023 98.59%
Dec 31, 2022 98.23%
Sep 30, 2022 98.37%
Jun 30, 2022 98.02%
Mar 31, 2022 97.45%
Dec 31, 2021 91.78%
Sep 30, 2021 97.20%
API Access

Acadia Pharmaceuticals Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=ACAD&period=max&api_key=YOUR_API_KEY